Notably, breast cancer cells achieve metabolic adaptation by hijacking the autophagy mechanism: under glucose-deprivation conditions, MANF-mediated mitophagy eliminates dysfunctional mitochondria through the PRKN/Parkin-dependent pathway, maintains the ATP supply and promotes tumour survival [112], suggesting that targeting the MANFPRKN interaction can break the drug resistance barrier of breast cancer under metabolic stress
This limitation restricts the utility of peptides for conditions where oral therapy would be strongly preferred
[3] Most GLP-1 medications require refrigeration before first use at temperatures between 36F and 46F (2C to 8C)
Key findings: Placebo Group : Minimal weight loss 1mg Daily Group : Average 2.8kg weight loss 5mg Daily Group : Comparable results to 1mg 10mg Daily Group : No additional benefits over 1mg This research established that doses above 1mg (1000 mcg) provide no additional benefits, supporting our 300-500 mcg dosing recommendations
Riboulet-Chavey, A., Diraison, F., Siew, L